ANIKA THERAPEUTICS INC's ticker is ANIK and the CUSIP is 035255108. A total of 171 filers reported holding ANIKA THERAPEUTICS INC in Q1 2018. The put-call ratio across all filers is 0.80 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2019 | $3,101,000 | +1007.5% | 59,808 | +1050.2% | 0.29% | +1281.0% |
| Q4 2017 | $280,000 | -74.1% | 5,200 | -77.0% | 0.02% | -73.1% |
| Q3 2016 | $1,082,000 | -80.8% | 22,629 | -78.4% | 0.08% | -80.0% |
| Q2 2016 | $5,631,000 | +13.5% | 104,969 | -5.4% | 0.39% | +17.8% |
| Q1 2016 | $4,962,000 | +155.6% | 110,969 | +118.1% | 0.33% | +136.4% |
| Q4 2015 | $1,941,000 | +396.4% | 50,882 | +430.0% | 0.14% | +438.5% |
| Q4 2014 | $391,000 | -81.7% | 9,600 | -83.5% | 0.03% | -81.2% |
| Q3 2014 | $2,134,000 | -83.8% | 58,231 | -79.5% | 0.14% | -84.4% |
| Q2 2014 | $13,175,000 | +12.7% | 284,393 | 0.0% | 0.88% | +10.1% |
| Q1 2014 | $11,688,000 | +49.8% | 284,393 | +39.1% | 0.80% | +21.9% |
| Q4 2013 | $7,800,000 | +82.7% | 204,417 | +14.3% | 0.66% | +52.0% |
| Q3 2013 | $4,270,000 | +981.0% | 178,767 | +668.3% | 0.43% | +802.1% |
| Q2 2013 | $395,000 | – | 23,268 | – | 0.05% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| HealthInvest Partners AB | 490,331 | $21,928,000 | 10.27% |
| CAPITAL MANAGEMENT CORP /VA | 211,660 | $9,465,000 | 3.66% |
| AMI ASSET MANAGEMENT CORP | 336,791 | $15,061,000 | 1.03% |
| Baltimore-Washington Financial Advisors, Inc. | 68,785 | $3,076,000 | 0.93% |
| Portolan Capital Management | 130,939 | $5,856,000 | 0.78% |
| Kalos Management, Inc. | 19,254 | $861,000 | 0.72% |
| DIKER MANAGEMENT LLC | 32,965 | $1,474,000 | 0.56% |
| THOMPSON SIEGEL & WALMSLEY LLC | 1,526,244 | $68,253,000 | 0.56% |
| NEW AMSTERDAM PARTNERS LLC/NY | 108,260 | $4,841,000 | 0.51% |
| Boston Trust Walden Corp | 493,780 | $22,082,000 | 0.38% |